GEN Exclusives

More »

GEN News Highlights

More »
May 31, 2007

Virbac Employs ProBioGen’s Avian Cell Lines to Manufacture Biological Products

  • Virbac entered into an agreement to use ProBioGen's avian cell lines to develop biological product candidates.

    Under the terms of the licensing deal, Virbac will use the permanent cell lines based on duck retina AGE1.cr and somite cells AGE1.cs.

    "This is a breakthrough in the commercialization of our avian cell line," notes Michael Schlenk, CEO of ProBioGen. "The development of new designer cell lines under the full guidelines of the FDA is a long and challenging process. We are very proud to have developed such a cell line, which not only satisfies these stringent requirements, but is also safe and cost effective for vaccine and biological production."



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »